This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,858.34 firm fixed-price delivery order is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 mL, a medication used for the treatment of type 2 diabetes. The contract has a completion date of December 17, 2024 and was awarded on December 16, 2024. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/17/25, 10:04 AM